Third Harmonic Bio News

Third Harmonic Bio Inc CEO Natalie Holles Sells 13,558 Shares

Yahoo FinanceApr 16 07:00

Third Harmonic Bio(THRD.US) Officer Sells US$165.21K in Common Stock

$Third Harmonic Bio(THRD.US)$ Officer Holles Natalie C. sold 13,558 shares of common stock on Apr 11, 2024 at an average price of $12.1857 for a total value of $165.21K.Source: Announcement What is st

Futu NewsApr 16 04:58

Third Harmonic Bio(THRD.US) Officer Sells US$11,070 in Common Stock

$Third Harmonic Bio(THRD.US)$ Officer Person Julie sold 1,107 shares of common stock on Apr 4, 2024 at an average price of $10 for a total value of $11,070.Source: Announcement What is statement of ch

Futu NewsApr 9 06:02

We're Not Worried About Third Harmonic Bio's (NASDAQ:THRD) Cash Burn

Yahoo FinanceApr 9 00:41

Here's Why We're Not At All Concerned With Third Harmonic Bio's (NASDAQ:THRD) Cash Burn Situation

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, Third Harmonic Bio (NASDAQ:THRD) shareholders have done very well over the last year, with the share

Simply Wall StApr 6 21:30

Third Harmonic Bio Welcomes New Director, Geoff McDonough

TipRanksMar 29 05:02

Press Release: Third Harmonic Bio Appoints Geoff McDonough, M.D., to Its Board of Directors

Third Harmonic Bio Appoints Geoff McDonough, M.D., to its Board of Directors SAN FRANCISCO, March 28, 2024 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a biopharmaceutical company foc

Dow JonesMar 28 20:30

Third Harmonic Bio Inc (THRD) Reports Decreased Net Loss in Q4, Aligns With Analyst Projections

Yahoo FinanceMar 27 09:02

Third Harmonic Bio GAAP EPS of -$2.45 Misses by $1.20

Seeking AlphaMar 27 03:36

Buy Rating for Third Harmonic Bio Amidst Promising Drug Pipeline and Market Potential

TipRanksMar 27 02:15

TD Cowen Remains a Buy on Third Harmonic Bio, Inc. (THRD)

TipRanksMar 26 22:16

Third Harmonic Bio Q4 EPS $(0.17) Beats $(0.31) Estimate

Third Harmonic Bio (NASDAQ:THRD) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.31) by 45.16 percent. This is a 52.78 percent increase over losses of $

BenzingaMar 26 21:26

Recap: Third Harmonic Bio Q4 Earnings

Third Harmonic Bio (NASDAQ:THRD) reported its Q4 earnings results on Tuesday, March 26, 2024 at 08:05 AM.Here's what investors need to know about the announcement.EarningsThird Harmonic Bio beat estim

BenzingaMar 26 21:25

Third Harmonic Bio Reported Q4 Net Loss of $(6.8)M, Cash Balance of $269.1M

Third Harmonic Bio Reported Q4 Net Loss of $(6.8)M, Cash Balance of $269.1M

BenzingaMar 26 20:14

Press Release: Third Harmonic Bio Announces Fourth Quarter and Full Year 2023 Financial Results

Third Harmonic Bio Announces Fourth Quarter and Full Year 2023 Financial Results U.S. IND filed for THB335 with anticipated clinical trial start during 2Q'24 Strong financial position with cash and

Dow JonesMar 26 20:05

Third Harmonic Bio 4Q EPS 78c >THRD

Third Harmonic Bio 4Q EPS 78c >THRD

Dow JonesMar 26 20:05

Third Harmonic Bio to Participate in the 44th Annual TD Cowen Health Care Conference

SAN FRANCISCO, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (NASDAQ:THRD), a biopharmaceutical company focused on advancing the next wave of medicine for inflammatory diseases, today announced that Chief

GlobeNewswireFeb 27 05:00

Third Harmonic Bio Taps Horizon Therapeutics Alum for Finance Chief

By Dean Seal Third Harmonic Bio has hired a former group vice president at Horizon Therapeutics to be its next chief financial officer. The biopharmaceutical company said Thursday that Christopher M

WSJJan 4 21:17

Third Harmonic Bio: IND-enabling Toxicology Studies of THB335 Nearing Completion; Pre-IND Interaction With the U.S. FDA Now Complete >THRD

Third Harmonic Bio: IND-enabling Toxicology Studies of THB335 Nearing Completion; Pre-IND Interaction With the U.S. FDA Now Complete >THRD

Dow JonesJan 4 21:04

Third Harmonic Bio: Program Remains on Track to File a U.S. IND and Initiate a Phase 1 Study of THB335 During the 1H of 2024 >THRD

Third Harmonic Bio: Program Remains on Track to File a U.S. IND and Initiate a Phase 1 Study of THB335 During the 1H of 2024 >THRD

Dow JonesJan 4 21:04